Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Neuropathy Clinical Trials
Neuropathy clinical trials are recruiting across 159 cities. Here are the cities with the most active studies:
Neuropathy Trial Phases
78 research organizations are sponsoring neuropathy trials.
About Neuropathy
Neuropathy refers to damage or dysfunction of peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet. Diabetes is the most common cause, but it can also result from infections, injuries, and autoimmune conditions. Treatment focuses on managing the underlying cause and pain relief.
Clinical trials are advancing new treatments for neuropathy. Currently, 100 studies are recruiting a combined 14,222 participants across the United States. Research is being conducted by 78 organizations including Vertex Pharmaceuticals Incorporated, University of Milano Bicocca, SWOG Cancer Research Network and 75 others.
2026 Neuropathy Research Landscape
As of July 2026, the neuropathy clinical trial landscape includes 100 actively recruiting studies across 159 cities in the United States. These studies are collectively seeking 14,222 participants, with an average enrollment target of 142 per study.
The research spans multiple phases of development: 34 studies are in NA, 22 studies are in PHASE2, 16 studies are in PHASE3, 8 studies are in PHASE1, 2 studies are in PHASE4, 2 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some neuropathy treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 78 different organizations, including Vertex Pharmaceuticals Incorporated, University of Milano Bicocca, SWOG Cancer Research Network, National Cancer Institute (NCI), Randy Kardon, and 73 others. The large number of sponsors reflects significant research interest and investment in neuropathy treatment advancement.
Geographically, neuropathy trials are most concentrated in Boston, Massachusetts (13 trials); New York, New York (11 trials); New Haven, Connecticut (9 trials); Houston, Texas (9 trials); Birmingham, Alabama (8 trials) and 7 other cities.
Featured Neuropathy Studies
Highlighted recruiting studies for neuropathy, selected by enrollment size and research scope.
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
International CIPN Assessment and Validation Study
This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
This phase III trial compares the effect of 3 study approaches in preventing chemotherapy-induced peripheral neuropathy: 1) cryocompression, 2) continuous compression, and 3) low cyclic compression. Taxane chemotherapy drugs, such as paclitaxel or docetaxel, can cause a nerve disorder called peripheral neuropathy, which can cause numbness, tingling, or pain in the arms and legs. The 3 study approa...
Frequently Asked Questions About Neuropathy Clinical Trials
Are there neuropathy clinical trials near me?
Yes, there are 100 neuropathy clinical trials currently recruiting across 159+ cities in the United States, including Boston, Massachusetts; New York, New York; New Haven, Connecticut. Browse the studies above to find one at a location convenient for you.
How do I join a neuropathy clinical trial?
To join a neuropathy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are neuropathy clinical trials free?
Yes, participation in neuropathy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of neuropathy treatments are being studied?
Current neuropathy clinical trials are testing a range of approaches across NA (34 studies), PHASE2 (22 studies), PHASE3 (16 studies), PHASE1 (8 studies), PHASE4 (2 studies), EARLY_PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 78 research organizations.
Is it safe to participate in neuropathy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 18, 2026 · Data from ClinicalTrials.gov